Edition:
United States

Motif Bio PLC (MTFB.OQ)

MTFB.OQ on NASDAQ Stock Exchange Capital Market

9.34USD
3:59pm EST
Change (% chg)

$0.21 (+2.30%)
Prev Close
$9.13
Open
$9.47
Day's High
$9.47
Day's Low
$9.29
Volume
1,900
Avg. Vol
1,572
52-wk High
$13.70
52-wk Low
$5.36

Latest Key Developments (Source: Significant Developments)

Motif Bio secures up to US$20 million debt financing
Wednesday, 15 Nov 2017 02:00am EST 

Nov 15 (Reuters) - Motif Bio Plc -:Motif Bio secures up to US$20 million debt financing.‍Company has entered into an agreement for up to US$20 million in debt financing with Hercules Capital, Inc​.‍Co shall issue Hercules warrants to purchase up to 73,452 of its American Depository Shares at exercise price of US$9.53 per ADS.  Full Article

Motif Bio ‍announces positive topline results for iclaprim in revive-2 phase 3 study​
Wednesday, 4 Oct 2017 02:00am EDT 

Oct 4 (Reuters) - Motif Bio Plc :POSITIVE TOPLINE RESULTS IN PHASE THREE STUDY.‍ANNOUNCES POSITIVE TOPLINE RESULTS FOR ICLAPRIM IN REVIVE-2 PHASE 3 STUDY​.‍ICLAPRIM WAS WELL TOLERATED IN STUDY​.‍NDA SUBMISSION EXPECTED IN Q1 OF 2018​.  Full Article

Motif Bio says iclaprim granted orphan drug designation by US FDA
Friday, 15 Sep 2017 09:07am EDT 

Sept 15 (Reuters) - MOTIF BIO PLC ::SAYS US FDA HAS GRANTED ITS INVESTIGATIONAL DRUG CANDIDATE, ICLAPRIM, ORPHAN DRUG DESIGNATION FOR TREATMENT OF STAPHYLOCOCCUS AUREUS LUNG INFECTIONS IN PATIENTS WITH CYSTIC FIBROSIS.  Full Article

Motif Bio says announces pricing of $25 mln U.S. IPO and European placing
Friday, 18 Nov 2016 08:47am EST 

Motif Bio Plc : Says each ADS, representing 20 ordinary shares of Motif, warrant to purchase 0.5 ADSs offered at price of $6.98/ADS and warrant combination .Says announces pricing of $25 million U.S. Initial public offering and European placing.  Full Article

Motif Bio sees IPO of 42.5 million ordinary shares
Thursday, 13 Oct 2016 06:03am EDT 

Motif Bio Plc : Motif Bio Plc sees IPO of 42.5 million ordinary shares including in form of American depositary shares - SEC filing .Motif Bio intends to use about $20.5 million of IPO proceeds to fund expenses to be incurred in conducting two Phase 3 clinical trials of Iclaprim.  Full Article

Motif Bio PLC sees U.S. IPO of 2.8 mln ADS - SEC filing
Wednesday, 27 Jul 2016 05:50pm EDT 

Motif Bio PLC : Sees U.S. IPO of 2.8 mln American Depositary Shares, representing 56 mln ordinary shares - SEC filing . Motif Bio PLC adds Ladenburg Thalmann to its list of underwriters to its U.S. IPO Source: (http://bit.ly/2aviFkr ) Further company coverage: [MTFB.L] (Bengaluru Newsroom: +1 646 223 8780).  Full Article

Motif Bio Plc files for U.S.IPO of $40.3 mln
Wednesday, 13 Jul 2016 06:24am EDT 

Motif Bio Plc : files for U.S.IPO of $40,3 million .says SunTrust Robinson Humphrey is underwriter to the IPO.  Full Article

BRIEF-Motif Bio secures up to US$20 million debt financing

* ‍Company has entered into an agreement for up to US$20 million in debt financing with Hercules Capital, Inc​